An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.

Phase 4 Completed 483 enrolled Johnson & Johnson Consumer and Personal Products Worldwide

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effectiveness and safety of acetaminophen extended release caplets and ibuprofen in relieving the muscle soreness that occurs after a marathon.

Timeline

Start: 2003-05
Primary completion: —
Completion: 2003-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Acetaminophen	Small molecule	1300 mg	Oral

Indications

No indication recorded.